• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LLC STRATA®; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LLC STRATA®; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number UNKNOWN-S
Device Problems Complete Blockage (1094); Infusion or Flow Problem (2964); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Cerebrospinal Fluid Leakage (1772); Headache (1880); Vomiting (2144)
Event Date 12/16/2019
Event Type  Injury  
Manufacturer Narrative
Patient information was unavailable from the site.Event date is the online publishing date of the literature article.Device lot number, or serial number, unavailable.510(k) is dependent upon the device model number and therefore, unavailable.No parts have been received by the manufacturer for evaluation.Device manufacturing date is dependent on lot number/serial number, therefore, unavailable.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Ludwig, h.C, reitemeyer, m., bock, h.C, sigler, m.Hydrocephalus shunt therapy: current titanium shunt valve implants obstructed by internal tissue proliferations identified as extracellular matrix membranes.Child's nervous system (2020) 36:2717¿2724.Https://doi.Org/10.1007/s00381-019-04467-8.Purpose shunt valves, required for treatment of hydrocephalus, demand for high performance rates and lifelong excellent function.To overcome problems with traditional silicone materials, adjustable and gravity-adapted titanium valves were developed.Even modern shunt valve systems are still subject to occlusion.The aim of the present study was to investigate dysfunctional silicone and titanium valves for presence of cellular and proteinous materials inside the housings by means of histopathology.Methods a total of 19 explanted shunt valves from children between 2 and 182 months of age were investigated following dysfunction.After fixation in formalin and embedding in hard resin, slices were ground to a thickness of 5¿30 ¿.Besides standard histology, immunohistochemistry was performed using antibodies with markers for microglia, astrocytes, platelets, monocytes, and the proteins laminin, fibronectin, and collagen iv.Results traces, layers, and plaques could be demonstrated in every investigated silicone or titanium valve with an implantation time of more than 6 days.Most of the tissue was found adjacent to silicone and titanium surfaces of the inner housing, the adjustment rotor, and ball-in-cone core.Markers for micro and astroglia stained positive in 40¿60% of the specimen, mostly demonstrating a proteinous layer positive for laminin (80%), fibronectin (30%), and collagen iv (30%).Conclusions tissue reactions with formation of cellular and proteinous matrix components are common in obstructed silicone and titanium shunt valves.The tissue mimics astrocytic repair mechanisms genuine for basilar membrane matrix.The knowledge of these typical arachnoid patterns of colonization is a prerequisite for developing future shunt devices.Reported events: the 10 valves had to be removed due to valve obstructions 1 valve was removed due to being defective.3 cases of infection with revisions 11 explanations were caused by occlusion or underdrainage in the case of partial occlusion independent from the proximal catheter.Headache and vomiting, and/or documentation of subgaleal cerebrospinal fluid (csf) collections.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA®
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
COVIDIEN LLC
15 hampshire street
mansfield 02048
Manufacturer (Section G)
COVIDIEN LLC
15 hampshire street
mansfield 02048
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key14193935
MDR Text Key290086957
Report Number9612501-2022-00638
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Model NumberUNKNOWN-S
Device Catalogue NumberUNKNOWN-S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/19/2022
Initial Date FDA Received04/25/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-